Stem cell therapy for myocardial repair

Heart

Volumn 91, Issue 5, 2005, Pages 696-702

  Weissberg, Peter L ^a   Qasim, Asif ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MARROW CELL; CELL DIFFERENTIATION; ENDOTHELIUM CELL; ETHICS; HEART MUSCLE PERFUSION; HUMAN; MUSCLE CELL; MYOCARDIAL DISEASE; MYOFIBROBLAST; NEOVASCULARIZATION (PATHOLOGY); NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; STEM CELL; SYSTEMATIC REVIEW; TISSUE REPAIR; TISSUE SPECIFICITY;

BONE MARROW TRANSPLANTATION; ENDOTHELIAL CELLS; HUMANS; MYOBLASTS, SKELETAL; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; MYOCYTES, CARDIAC; STEM CELL TRANSPLANTATION;

EID: 17644427735     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2004.038224     Document Type: Review

References (22)

1. Pera MF, Reubinoff B, Trounson A. Human embryonic stem cells. J Cell Sci 2000;113(Pt 1):5-10. This is a comprehensive review of the derivation, culture and properties of embryonic stem cells and their potential in biomedical research.
2. Fukuda K. Use of adult marrow mesenchymal stem cells for regeneration of cardiomyocytes. Bone Marrow Transplant 2003;32(suppl 1):S25-7. This paper demonstrated the capacity of bone marrow stromol cells to differentiate into cardiomyocytes in vitro, developing a murine cardiomyogenic cell line using 5-ozocytadine treatment.
3. Hirschi KK, Goodell MA. Hematopoietic, vascular and cardiac fates of bone marrow-derived stem cells. Gene Ther 2002;9:648-52.
4. Kehat I, Kenyagin-Karsenti D, Snir M, et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 2001;108:407-14.
5. Klug MG, Soonpaa MH, Koh GY, et al. Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts. J Clin Invest 1996;98:216-24.
6. Hwang WS, Ryu YJ, Park JH, et al. Evidence of a pluripotent human embryonic stem cell line derived from a cloned blastocysr. Science 2004;Sciencexpress:1094515.
7. Murry CE, Wiseman RW, Schwartz SM, et al. Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Invest 1996;98:2512-23.
8. Menasche P, Hagege AA, Vilquin JT, et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 2003;41:1078-83. This paper established the feasibility of human cellular cardiomyoplasiy for myocardial repair using skeletal myoblasts after acute myocardial infarction, with contraction seen in previously akinetic myocardium. However, patients suffered high rates of ventricular arrhythmias requiring cardioverter-defibrillator implantation.
9. Beltrami AP, Urbanek K, Kajstura J, et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 2001;344:1750-7. This paper challenged the dogma that the adult heart is a post-mitotic organ and suggested that there may be a population of cardiac stem cells involved in myocardial repair.
10. Bianco P, Gehron RP. Marrow stromal stem cells. J Clin Invest 2000;105:1663-8.
11. Orlic D, Kajstura J, Chimenti S, et al. Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann N Y Acad Sci 2001;938:221-9. This paper showed that bone marrow stromal cells engrafted and survived in infarcted mouse hearts, and differentiated to express a range of cardiomyocyte markers.
12. Toma C, Pittenger MF, Cahill KS, et al. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002;105:93-8.
13. Muller P, Pfeiffer P, Koglin J, et al. Cardiomyocytes of noncardiac origin in myocardial biopsies of human transplanted nearts. Circulation 2002;106:31-5.
14. Deb A, Wang S, Skelding KA, et al. Bone marrow-derived cardiomyocytes are present in adult human heart: a study of gender-mismatched bone marrow transplantation patients. Circulation 2003;107:1247-9.
15. Strauer BE, Brehm M, Zeus T, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002;106:1913-8.
16. Assmus B, Schachinger V, Teupe C, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 2002;106:3009-17. This clinical study used intracoronary injection of autologous bone marrow derived or circulating progenitor cells after acute myocordial infarction. Both treatments improved myocordial contractile function when compared with on untreated reference group of control patients. The authors have initiated a randomised controlled trial based on this pilot study.
17. Britten MB, Abolmaali ND, Assmus B, et al. Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation 2003;108:2212-8.
18. Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999;85:221-8.
19. Kawamoto A, Tkebuchava T, Yamaguchi J, et al. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 2003;107:461-8.
20. Jackson KA, Majka SM, Wang H, et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 2001;107:1395-402.
21. Iwaguro H, Yamaguchi J, Kalka C, et al. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 2002;105:732-8.
22. Kang H-J, Kim S, Zhang Y, et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 2004;363:751-6. This randomised trial examined the effects of coronary artery administration of bone marrow stem cells after culprit vessel stent insertion following acute myocardial infarction. Compared to untreated control patients, myocardial perfusion and exercise tolerance were improved in the treated group. However, recruitment to the trial was halted because of high rate of in-stent restenosis in patients who received g-CSF.